搜索临床试验以:SHR-1209 安慰剂
总计55892个结果
-
Eli Lilly and Company完全的A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)斑块状银屑病德国, 西班牙, 比利时, 法国, 匈牙利, 奥地利, 加拿大, 意大利, 荷兰, 波兰, 瑞典, 瑞士, 英国
-
Agomab Spain S.L.招聘中
-
Sun Pharma Advanced Research Company Limited完全的
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Fudan UniversityShanghai Shen Kang Hospital Development Center招聘中
-
Shanghai Chest Hospital尚未招聘
-
TG Therapeutics, Inc.SCRI Development Innovations, LLC完全的
-
Bristol-Myers Squibb完全的
-
Regeneron Pharmaceuticals终止
-
Beijing Ditan Hospital完全的
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteTG Therapeutics, Inc.终止
-
Ipsen招聘中
-
AVIR Green Hills Biotechnology AGMedical University of Vienna完全的
-
TG Therapeutics, Inc.终止慢性淋巴细胞白血病 | 非霍奇金淋巴瘤美国
-
Janssen Research & Development, LLC完全的
-
Nymox Corporation完全的
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.完全的